Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Kallioniemi

Showing results (101-110 of 184) with videos related to

Pageof 19
Sort By:
Developmental Cell|September 23, 2008
Integrin trafficking regulated by Rab21 is necessary for cytokinesisTeijo Pellinen, Saara Tuomi, Antti Arjonen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
CIP2A is associated with human breast cancer aggressivityChristophe Côme, Anni Laine, Maïa Chanrion, et al.
Plos One|October 27, 2011
Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cellsSanna Siltanen, Tiina Wahlfors, Martin Schindler, et al.
Nature|February 18, 2015
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformationTea Pemovska, Eric Johnson, Mika Kontro, et al.
Genome Research|October 4, 2003
RNAi microarray analysis in cultured mammalian cellsSpyro Mousses, Natasha J Caplen, Robert Cornelison, et al.
Cancer Research|September 30, 2010
Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradationNami Sugiyama, Markku Varjosalo, Pipsa Meller, et al.
Neoplasia (New York, N.Y.)|September 29, 2012
MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancerLina Cekaite, Juha K Rantala, Jarle Bruun, et al.
Neoplasia (New York, N.Y.)|November 18, 2010
Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2Juha K Rantala, Henrik Edgren, Laura Lehtinen, et al.
European Urology Focus|March 18, 2023
Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic TargetsSilvia Angori, Amir Banaei-Esfahani, Katharina Mühlbauer, et al.
Cancer Research|July 5, 2005
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal developmentRolf I Skotheim, Guro E Lind, Outi Monni, et al.
Pageof 19

Showing results (101-110 of 184) with videos related to

Sort By:
Pageof 19
Developmental Cell|September 23, 2008
Integrin trafficking regulated by Rab21 is necessary for cytokinesisTeijo Pellinen, Saara Tuomi, Antti Arjonen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
CIP2A is associated with human breast cancer aggressivityChristophe Côme, Anni Laine, Maïa Chanrion, et al.
Plos One|October 27, 2011
Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cellsSanna Siltanen, Tiina Wahlfors, Martin Schindler, et al.
Nature|February 18, 2015
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformationTea Pemovska, Eric Johnson, Mika Kontro, et al.
Genome Research|October 4, 2003
RNAi microarray analysis in cultured mammalian cellsSpyro Mousses, Natasha J Caplen, Robert Cornelison, et al.
Cancer Research|September 30, 2010
Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradationNami Sugiyama, Markku Varjosalo, Pipsa Meller, et al.
Neoplasia (New York, N.Y.)|September 29, 2012
MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancerLina Cekaite, Juha K Rantala, Jarle Bruun, et al.
Neoplasia (New York, N.Y.)|November 18, 2010
Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2Juha K Rantala, Henrik Edgren, Laura Lehtinen, et al.
European Urology Focus|March 18, 2023
Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic TargetsSilvia Angori, Amir Banaei-Esfahani, Katharina Mühlbauer, et al.
Cancer Research|July 5, 2005
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal developmentRolf I Skotheim, Guro E Lind, Outi Monni, et al.
Pageof 19